Experimental mRNA cancer vaccine shows potential for patients with advanced cancer in phase 1 trial
Interim data from a Phase I dose-escalation trial of mRNA cancer immunotherapy (mRNA-4359) are promising in patients with advanced solid… Read More »Experimental mRNA cancer vaccine shows potential for patients with advanced cancer in phase 1 trial